Abstracts tagged "Still’s disease and prognostic factors"

Abstract Number: 269 • 2015 ACR/ARHP Annual Meeting
Items of Yamaguchi Criteria Might be Associated with Disease Severity and Prognosis in Adult-Onset Still’s Disease
Umut Kalyoncu¹, Dilek Solmaz², Hakan Emmungil³, Ayten Yazici⁴, Timucin Kasifoglu⁵, Gezmis Kimyon⁶, Ayse Balkarli⁷, Cemal Bes⁸, Mustafa Ozmen⁹, Fatma Alibaz-Oner¹⁰, Sukran Erten¹¹, Yonca Cagatay¹², Gozde Cetin¹³, Sedat Yılmaz¹⁴, Fatih Yildiz¹⁵, Omer Nuri Pamuk¹⁶, Orhan Kucuksahin¹⁷, Levent Kilic¹, Abdulsamet Erden¹, Veli Yazisiz¹⁸, Omer Karadag¹, Suleyman Serdar Koca¹⁹, Mutlu Hayran²⁰, Servet Akar², Kenan Aksu²¹, Nurullah Akkoc²², Gokhan Keser²³, Emel Gonullu²⁴, Bunyamin Kisacik²⁵, Ahmet Mesut Onat²⁵, Mehmet Soy²⁶, Nevsun Inanc²⁷, Haner Direskeneli²⁸, Mehmet Sayarlioglu²⁹, Eren Erken³⁰, Murat Turgay³¹, Ayse Cefle³², Ihsan Ertenli¹ and Salih Pay³³, ¹Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey, ²Rheumatology, Dokuz Eylül University Faculty of Medicine, Izmir, Turkey, ³Rheumatology, Ege University Faculty of Medicine, Izmir, Turkey, ⁴Rheumatology, Kocaeli University, Faculty of Medicine, Kocaeli, Turkey, ⁵Rheumatology, Eskisehir Osmangazi University School of Medicine, Eskisehir, Turkey, ⁶Department of Rheumatology, Gaziantep University School of Medicine, Gaziantep, Turkey, ⁷Department of Rheumatology, Pamukkale University School of Medicine, Denizli, Turkey, ⁸Rheumatology, Bolu Izzet Baysal School of Medicine, Bolu, Turkey, ⁹Rheumatology, Izmir Ataturk Research and Training Hospital, Izmir, Turkey, ¹⁰Department Rheumatology, Marmara University Faculty of Medicine, Istanbul, Turkey, ¹¹Rheumatology, Ataturk Training and Research Hospital, Ankara, Turkey, ¹²Department of Rheumatology, Bilim University Faculty of Medicine, Istanbul, Turkey, ¹³Rheumatology, Sutcu Imam University Faculty of Medicine, Kahramanmaras, Turkey, ¹⁴PsART study group, Ankara, Turkey, ¹⁵Rheumatology, Cukurova University, School of Medicine, Adana, Turkey, ¹⁶Department of Rheumatology, Trakya University Medical Faculty, Edirne, Turkey, ¹⁷Rheumatology, Yildirim Beyazit University School of Medicine, Ankara, Turkey, ¹⁸Rheumatology, Akdeniz University School of Medicine, Antalya, Turkey, ¹⁹İnternal Medicine Division of Rheumatology, Firat University, Faculty of Medicine, Elazig, Turkey, ²⁰Preventive Oncology, Hacettepe University Faculty of Medicine, Ankara, Turkey, ²¹Rheumatology, Ege University School of Medicine, Izmir, Turkey, ²²Department of Rheumatology, Dokuz Eylul University, Faculty of Medicine, Izmir, Turkey, ²³Rheumatology, Ege University Medical Faculty, Izmir, Turkey, ²⁴Rheumatology, Osmangazi University, Faculty of Medicine, Eskisehir, Turkey, ²⁵Rheumatology, Gaziantep University School of Medicine, Gaziantep, Turkey, ²⁶Rheumatology, Abant Izzet Baysal University Faculty of Medicine, Bolu, Turkey, ²⁷Marmara University Faculty of Medicine, Rheumatology, Istanbul, Turkey, ²⁸Rheumatology, Marmara University, Faculty of Medicine, Istanbul, Turkey, ²⁹Department of Internal Medicine Division of Rheumatology, Ondokuz Mayıs University, Faculty of Medicine, Samsun, Turkey, ³⁰Rheumatology, Cukurova University Faculty of Medicine, Adana, Turkey, ³¹Internal Medicine-Rheumatology, Ankara University School of Medicine, Ankara, Turkey, ³²Rheumatology, Kocaeli University Faculty of Medicine, Kocaeli, Turkey, ³³Rheumatology, Gulhane School of Medicine, Ankara, Turkey
Background/Purpose: Widely accepted outcome measures for disease activity and severity at Adult Onset Still's Disease (AOSD) is not developed until now. Predictive factors for worse…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].